Overview

A Drug-Drug Interaction Study Evaluating the Combination of IDX320 and IDX184 in Healthy Participants (MK-6844-002)

Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate the potential for a pharmacokinetic (PK) drug-drug interaction between IDX320 and IDX184 and to assess the safety and tolerability when the two drugs are administered in combination in healthy participants.
Phase:
Phase 1
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.